CRBP Stock: Insider & Congress Trades

Smart money at a glance

Filings to Nov 14, 2026

Net selling: insiders sold $1.8M and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.

Company insidersForm 4, 90 days: -$1.8M net
CongressSTOCK Act, 180 days: None
Big funds13F, quarter ended Jun 30, 2026: 1 added, 0 cut
Federal contractsUSAspending.gov, 12 months: No awards

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

Unlock the full results

Questions about CRBP filings

Are insiders buying or selling Corbus Pharmaceuticals Holding (CRBP) stock?

Net selling: insiders sold $1.8M and bought $0 of CRBP stock on the open market in the 90 days to Nov 14, 2026, according to SEC Form 4 filings. $16K of the sales were made under pre-set Rule 10b5-1 trading plans. The largest was Cormorant Global Healthcare Master Fund, LP (Insider), who sold $1.7M. The latest filing was on Nov 2, 2026.

Which members of Congress have traded CRBP recently?

None. No member of Congress disclosed a CRBP trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this CRBP smart-money data?

This summary uses filings available on Nov 14, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.

13F: filed up to 45 days late.

Smart money on CRBP

Lean long1 source:
- Funds
Lean short1 source:
- Insiders

Top traders
No tracked positions at the last update
Insiders
Lean short1 buy · 2 sales
1 of 3 on scheduled plans. Form 4 filings.
Congress
No recent politician filings found
Funds
- BlackRock, added +$9.9M, holdings at Jun 30
Lean long · thin1 added · 0 trimmed
Quarter-end 13F holdings changes, not live trades. A trim is not a short.
Influencers
No recent posts found

Each bar is 100% of that source’s money. The notch marks an even split.

Lean is the direction of the latest moves. Descriptive, not advice.

Questions about CRBP filings

Are insiders buying or selling Corbus Pharmaceuticals Holding (CRBP) stock?

Net selling: insiders sold $1.8M and bought $0 of CRBP stock on the open market in the 90 days to Nov 14, 2026, according to SEC Form 4 filings. $16K of the sales were made under pre-set Rule 10b5-1 trading plans. The largest was Cormorant Global Healthcare Master Fund, LP (Insider), who sold $1.7M. The latest filing was on Nov 2, 2026.

Which members of Congress have traded CRBP recently?

None. No member of Congress disclosed a CRBP trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this CRBP smart-money data?

This summary uses filings available on Nov 14, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.

Funds

What funds are doing

1 move · 6 mo

Buys/Adds$9.9M

Buys/Adds (1)

BR
BlackRock
Q2 2026 13F
$9.9M
added
Signals like this: n=13773, 53% finished lower at D15, median -0.4% vs SPY -0.4%

Unlock everything for $29/month

Unlock for $29/month

Reported Nov 10, 2026

Earnings came in 42.3% below what analysts expected.

Documents

Quarterly report10-Q Annual report10-K Every filing

Last report

Nov 10, 2026

Period ending

Sep 30, 2026

Earnings per share

-$1.81-42.30% miss

-$1.27 expected

Revenue

$0.00

Yahoo Finance

EPS and revenue: Yahoo Finance

Next report

What the street expects next

Previous reports

Quarter / reported	Earnings per share	Beat or miss	Revenue / income	Revenue vs last year
Sep 30, 2026Reported Nov 10, 2026	-$1.81est. -$1.27	-42.30%miss	$0.00Yahoo Finance	No year-ago quarter
Jun 30, 2026Reported Aug 6, 2026	-$1.81est. -$1.30	-39.23%miss	Not on file	Not on file
Mar 31, 2026Reported May 12, 2026	-$1.23est. -$1.22	-0.82%in line	$0.00Yahoo Finance	No year-ago quarter
Dec 31, 2025Reported Mar 9, 2026	-$1.25est. -$1.58	+20.69%beat	$0.00Yahoo Finance	No year-ago quarter
Sep 30, 2025Reported Nov 12, 2025	-$1.90est. -$1.71	-11.31%miss	Not on file	Not on file
Jun 30, 2025Reported Aug 5, 2025	-$1.44est. -$1.33	-8.27%miss	Not on file	Not on file
Mar 31, 2025Reported May 6, 2025	-$1.39est. -$1.07	-29.91%miss	Not on file	Not on file
Dec 31, 2024Reported Mar 11, 2025	-$0.78est. -$1.26	+38.04%beat	Not on file	Not on file

Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.

Open: $4.00
High: $4.01
Low: $3.23
Prev close: $4.00
52-wk high: $12.88
52-wk low: $2.81
Mkt cap: $82.4M
ROE: -131.5%
Beta: 2.79
P/S: 169.9x
P/B: 1.0x
Profit margin: +0.0%
Op margin: +0.0%

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $82M

Valuation

P/S169.88
P/B0.96

Quality

Operating margin0.0%
ROE-131.5%
ROA-65.2%

Growth

Beta2.79

Technicals

Price structure

This stock is under pressure.

Trend

Under pressure

0 / 100

RSI 14

41balanced

20D volatility

130%annualized

52-week range

$3.41

$2.81$12.88

20D support

$2.81recent floor

20D resistance

$4.72recent ceiling

Returns

5D +19.2%20D -21.2%60D -65.9%

Price vs moving averages

SMA20 -13.5%SMA50 -41.5%SMA200 -59.3%

Volume pace

1.34xvs prior 20D

Corbus Pharmaceuticals Holding

Smart money at a glance

What do analysts expect?

Questions about CRBP filings

Smart money on CRBP

Questions about CRBP filings

What funds are doing

What insiders are doing

How top traders are positioned

Unlock everything for $29/month

Earnings came in 42.3% below what analysts expected.

What the street expects next

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

Corbus Pharmaceuticals Holding

Smart money at a glance

What do analysts expect?

Questions about CRBP filings

Smart money on CRBP

Questions about CRBP filings

What funds are doing

What insiders are doing

How top traders are positioned

Unlock everything for $29/month

Earnings came in 42.3% below what analysts expected.

What the street expects next

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

Corbus Pharmaceuticals Holding

Overview

Questions about CRBP filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Ask it in Claude or ChatGPT.

Corbus Pharmaceuticals Holding

Overview

Questions about CRBP filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Ask it in Claude or ChatGPT.